Incidence of Relapse and Post-Kala-Azar Dermal Leishmaniasis in South Sudan
Condition(s):Leishmaniasis; Leishmaniasis, Visceral; Post-kala-azar Dermal LeishmaniasisLast Updated:September 25, 2023Recruiting
Include Studies Not Open or Pending
Condition(s):Leishmaniasis; Leishmaniasis, Visceral; Post-kala-azar Dermal LeishmaniasisLast Updated:September 25, 2023Recruiting
Condition(s):Visceral LeishmaniasisLast Updated:June 22, 2022Recruiting
Condition(s):Cutaneous LeishmaniasesLast Updated:May 22, 2023Recruiting
Condition(s):LeishmaniasisLast Updated:March 12, 2024Recruiting
Condition(s):Leishmaniasis; Brazilian; Leishmaniasis, MucocutaneousLast Updated:September 15, 2023Recruiting
Condition(s):Primary Visceral LeishmaniasisLast Updated:February 28, 2024Not yet recruiting
Condition(s):Leishmaniasis; American, Cutaneous; Drug Side EffectLast Updated:March 19, 2020Not yet recruiting
Condition(s):Leishmaniasis, CutaneousLast Updated:May 10, 2023Recruiting
Condition(s):Visceral LeishmaniasisLast Updated:November 21, 2023Recruiting
Condition(s):Visceral LeishmaniasisLast Updated:April 7, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.